Compound Profile: Ultima-HGH Fragment 176-191
Ultima-HGH Fragment 176-191 is a synthetic peptide comprising amino acids 176-191 from the C-terminal region of human growth hormone. This 16-amino acid sequence represents the lipolytic domain of growth hormone, extensively studied for its metabolic effects without the anabolic properties of the full-length hormone. Research indicates this fragment retains fat-oxidation promoting activities while demonstrating reduced growth-promoting effects compared to complete growth hormone. Laboratory investigations have focused on its role in lipid metabolism pathways and cellular energy utilisation mechanisms. The peptide’s selective activity profile makes it valuable for metabolic research applications where investigators seek to study specific aspects of growth hormone signalling without broader systemic effects.
Laboratory Applications
Research scientists study this fragment for investigating metabolic pathways, particularly those involving lipolysis and energy expenditure mechanisms. The compound has been examined in cellular models for its effects on adipocyte function and lipid mobilisation pathways. Studies have explored its potential mechanisms in metabolic syndrome research and obesity-related investigations. Researchers at Stroid UK Shop can access high-quality peptides for advanced metabolic studies. The fragment’s selectivity allows for precise investigation of growth hormone’s metabolic functions while avoiding confounding growth-promoting effects. Scientists examining HGH fragment research applications value its targeted activity profile. Laboratories studying selective receptor modulators often compare peptide mechanisms with other compounds. Metabolic researchers frequently investigate this fragment alongside other research peptides for comprehensive pathway analysis.
Product Specifications
| Parameter | Specification |
|---|---|
| Sequence | 176-191 amino acid region of hGH |
| Purity | Verify with supplier |
| Form | Lyophilised powder |
| Storage | -20°C (dry), 2-8°C (reconstituted) |
| Molecular Weight | Approximately 1.8 kDa |
| Solubility | Water, saline buffer |
| Stability | 24 months dry, 30 days reconstituted |
Research Compliance
This product is manufactured by Ultima Peptides exclusively for in-vitro research purposes. The compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper handling protocols and waste disposal procedures are followed. All studies should be conducted by qualified personnel with appropriate safety equipment and institutional oversight. This material is restricted to scientific investigation only.
